Disease/Infection News

RSS

Immune particles from llama blood could offer protection against several COVID-19 variants

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses including SARS-CoV-2 and SARS-CoV-1, which was responsible for the 2003 SARS outbreak.

29 Jun 2022

Drug-resistant typhoid needs to be treated as a global problem

The bacteria that causes typhoid fever is becoming increasingly resistant to common antibiotics used to treat the disease, with resistant strains spreading to hundreds of countries in the past three decades, new analysis shows.

29 Jun 2022

How has COVID-19 affected the mental health of prison staff in England?

In a recent study posted to the medRxiv* preprint server, researchers at the University of Southampton, University of Manchester, and the UK Health Security Agency analyzed the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on the mental well-being of prison staff in England.

29 Jun 2022

Study reveals how COVID-19 pandemic has changed the way people perceive the passage of time

The COVID-19 pandemic has changed the way people perceive the passage of time, according to an article published in the journal Science Advances.

28 Jun 2022

Neural effects of COVID-19 on depressive symptoms

A new study identifies brain abnormalities in patients who recovered from COVID-19.

28 Jun 2022

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

In a recent study posted to the medRxiv* pre-print server, Canadian researchers evaluated antibody responses in kidney transplant recipients (KTRs) before and one and three months after receiving the third dose of a messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine.

28 Jun 2022

Study compares protection induced by Delta breakthrough infections vs. COVID boosters against Omicron

Researchers compare the neutralizing ability of antibodies induced by Delta breakthrough infections and a third COVID-19 vaccine against Omicron.

28 Jun 2022

BNT162b2 COVID vaccine stimulates significant antibody response in lung cancer patients

In a recent article posted to the medRxiv* preprint server, scientists from Japan assessed the safety and immunogenicity of coronavirus disease 2019 (COVID-19) BNT162b2 vaccine among lung cancer patients under treatment.

28 Jun 2022

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

IgA and IgG in human breast milk and blood were assessed for their activity against SARS-CoV-2 and SARS-CoV-1, as well as four other prevalent HCoVs.

28 Jun 2022

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) SP1-77 that broadly neutralized its multiple variants of concern (VOCs).

28 Jun 2022

Should monkeypox be considered a sexual transmitted infection?

The present monkeypox outbreak is marked by sustainable human-to-human transmission.

28 Jun 2022

COVID-19 mortality rates by race and ethnicity in U.S. state prisons

In a recent study posted to the medRxiv* pre-print server, researchers estimated the rate of coronavirus disease 2019 (COVID-19) cases and deaths among individuals incarcerated in the state prisons of the United States (U.S.).

28 Jun 2022

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

New CDC data published ahead of National HIV Testing Day (Monday, June 27) show a sharp decrease in the number of CDC-funded HIV tests administered in health care and non-health-care settings (43% and 50%, respectively) from 2019 to 2020, the first year of the COVID-19 pandemic.

28 Jun 2022

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland.

28 Jun 2022

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Scientists from China have recently deciphered the genetic network and biological mechanisms associated with COVID-19 myocarditis using bioinformatic methods.

28 Jun 2022

Low rates of severe COVID-19 found in patients treated with monoclonal antibodies during delta surge

A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low rates of severe disease, hospitalization, ICU admission and mortality, according to Mayo Clinic researchers.

28 Jun 2022

Disease/Infection News

Immune particles from llama blood could offer protection against several COVID-19 variants

Drug-resistant typhoid needs to be treated as a global problem

How has COVID-19 affected the mental health of prison staff in England?

Study reveals how COVID-19 pandemic has changed the way people perceive the passage of time

Neural effects of COVID-19 on depressive symptoms

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

Study compares protection induced by Delta breakthrough infections vs. COVID boosters against Omicron

BNT162b2 COVID vaccine stimulates significant antibody response in lung cancer patients

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Should monkeypox be considered a sexual transmitted infection?

COVID-19 mortality rates by race and ethnicity in U.S. state prisons

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Low rates of severe COVID-19 found in patients treated with monoclonal antibodies during delta surge

The mental health status and menstrual changes in hospitalized female COVID-19 patients

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

Highly antibiotic-resistant strain of MRSA on pigs is capable of rapidly adapting to human hosts

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News